Intracellular Therapies
1 known investors
Find your way into Intracellular Therapies
Sign up to find every way you can get introduced to Intracellular Therapies
- Your email: who you already know at Intracellular Therapies, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Intracellular Therapies team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
A biopharmaceutical company developing treatments for psychiatric and neurologic disorders based on research into how therapies affect cellular mechanisms. The company, now part of Johnson & Johnson, focuses on innovative therapies for patients with complex brain-related diseases.
Founders & leadership
PG

Paul Greengard
Investors · 1
Frequently asked questions
- What does Intracellular Therapies do?
- A biopharmaceutical company developing treatments for psychiatric and neurologic disorders based on research into how therapies affect cellular mechanisms. The company, now part of Johnson & Johnson, focuses on innovative therapies for patients with complex brain-related diseases.
- Who founded Intracellular Therapies?
- Intracellular Therapies was founded by Paul Greengard.
- Who are Intracellular Therapies's investors?
- Intracellular Therapies's investors include Scientia Ventures.